TECH gears up for Q3 results with modest revenue growth expected as biotech funding trends and product momentum shape the ...
Shares of Bio-Techne Corp. plunged 10.89% to $52.20 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.41% to 7,108.40 and Dow ...
At analytica 2026, Bio‑Techne’s Dr. Simon Sumer highlighted how these tools cut development cycles, improve data consistency, and shift required lab skills. The changes come amid broader adoption of ...
Dr. Simon Sumer explains how AI‑driven protein design is shortening development cycles, improving screening efficiency, and ...
Minnesota-based UnitedHealth ( UNH) reported $111.7B in revenue for the quarter with ~2% YoY growth, exceeding the consensus by $2.1B, thanks mainly to its insurance segment. Meanwhile, its non-GAAP ...
Intel forecast stronger-than-expected Q2 revenue of $13.8–$14.8 billion, driven by robust demand for AI-focused server chips, ...
John Maynard Keynes' insight that investment results rarely match initial expectations underscores the inherent uncertainty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results